|
|
Humanscape
| Humanscape | |
|---|---|
|
Humanscape logo Humanscape ICO Review | |
| Humanscape ICO | |
| Ticker: | HUM |
| ICO start: | 0000-00-00 00:00:00 |
| ICO end: | 0000-00-00 00:00:00 |
| Price: | 1 HUM = 0.01 USD |
| Bonus: | 1 |
| Tokens: | 1,000,000,000 HUM |
| Tokentype: | ERC20 |
| Hardcap: | 10,000,000 USD |
| Platform: | Ethereum |
| Distributed: | 40% |
| Accepting: | ETH |
Humanscape can provide practical help for patients to overcome their diseases through intellectual and emotional interaction with each other based on community activities. This process is expected to generate and collect a high volume of patient data, namely PGHD, on various disease groups.
Furthermore, Humanscape facilitates active research into incurable diseases and the development of new drugs by linking patients to external industry sectors such as pharmaceutical firms and research institutes and helps patients to avoid complications and enjoy healthy lives through the continuous self-management of their lifestyle and symptoms.
With these services, Humanscape is taking steps to liberate patients from incurable diseases, as its contribution to a world where everyone is healthy.
Description
Patient’s personal health profile, such as daily records of illness, associated symptoms, administered medication and IoT data can be entered and managed altogether in profile section. Under patients’ permission, this data can be utilized for researches and clinical studies, ultimately bringing better chances for recovery.
Health records shared by patients, currently scattered around different patient communities focused on certain diseases, can be browsed in a single platform. The rarer disease it is, the less information is available. In this respect, every little piece of information is valuable and can be a great help.
When it comes to incurable or rare diseases, relatively small amount of patient data can be still useful for pharmaceutical companies and clinical studies institutes to gather target patients and conduct researches. For example, in 2011, there was a case which existing medical research paper was refuted by 149 ASL patients’ data.
Roadmap
| “ | Q1 2016: Company Incorporation - Seoul, Korea (team foundation : 2014) Q2 2016: Development and Launch of ‘Beautycare’, a mobile application for aftercare services Q3 2016: Angel Investment Promotion from ‘Mashup Angels’ (Taek-Kyung Lee, CEO and Founder of ‘Daum’) Q4 2016: Client Usage Agreement with ‘Dream Medical Group’ and ‘DA Plastic Surgery’ Q1 2017: Development and Beta test of ‘Helen’, Mobile Medical Assistant Q2 2017: Official Launch of ‘Helen’ Q3 2017: Follow-up Investment Promotion from ‘Magellan Technology Investment(VC)’ Q4 2017: Acquisition of 10,000 PHR Data from ‘Beautycare’ and ‘Helen’ Concept Building of ‘Humanscape’, a Health Information Ecosystem Q1 2018: Whitepaper publication Company Incorporation - Hongkong Q2 2018: ‘Humanscape’ MVP Development Begins Pre-sale 1st, 2nd and 3rd round Q3 2018: Main sale Test group(patients/health professionals) building Indonesia incorporation / Organization PoC Q4 2018: Exchange listing MVP release Alpha test PoC with global pharmaceutical companies and Contract research institutes Q1 2019: Beta test closing Soft launch (South Korea, Indonesia) Business model validation Q2 2019: Main launch (South Korea, Indonesia)[1] | ” |
Team
External links
Humanscape on Twitter
Humanscape on Telegram
Humanscape on Facebook
Humanscape on Medium
Humanscape on Bitcointalk
Humanscape on Github
Humanscape on Reddit
Humanscape on Youtube
Humanscape Official Website
Humanscape Bounty
Humanscape Whitepaper
